NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 365 filers reported holding NEKTAR THERAPEUTICS in Q1 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $331,000 | -8.8% | 9,289 | -14.0% | 0.00% | 0.0% |
Q1 2019 | $363,000 | +2.3% | 10,807 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $355,000 | -45.9% | 10,807 | +0.4% | 0.00% | -50.0% |
Q3 2018 | $656,000 | +51.2% | 10,768 | +21.2% | 0.00% | 0.0% |
Q2 2018 | $434,000 | +4.8% | 8,883 | +127.9% | 0.00% | 0.0% |
Q1 2018 | $414,000 | +10250.0% | 3,897 | +1819.7% | 0.00% | – |
Q2 2017 | $4,000 | -78.9% | 203 | -88.7% | 0.00% | – |
Q1 2017 | $19,000 | +26.7% | 1,803 | -14.3% | 0.00% | – |
Q4 2016 | $15,000 | -28.6% | 2,103 | +75.0% | 0.00% | – |
Q3 2016 | $21,000 | +162.5% | 1,202 | +118.5% | 0.00% | – |
Q2 2016 | $8,000 | -98.6% | 550 | -98.6% | 0.00% | -100.0% |
Q1 2016 | $559,000 | -16.1% | 40,650 | +2.8% | 0.00% | -20.0% |
Q4 2015 | $666,000 | +38.5% | 39,550 | -9.8% | 0.01% | +25.0% |
Q3 2015 | $481,000 | -11.7% | 43,850 | +0.7% | 0.00% | -20.0% |
Q2 2015 | $545,000 | +21.1% | 43,550 | +6.5% | 0.01% | +25.0% |
Q1 2015 | $450,000 | -48.6% | 40,900 | -27.6% | 0.00% | -55.6% |
Q4 2014 | $876,000 | +26.2% | 56,500 | -1.7% | 0.01% | +12.5% |
Q3 2014 | $694,000 | +14.0% | 57,500 | +21.1% | 0.01% | 0.0% |
Q2 2014 | $609,000 | +5.2% | 47,500 | -0.5% | 0.01% | -11.1% |
Q1 2014 | $579,000 | +7.2% | 47,750 | +0.4% | 0.01% | 0.0% |
Q4 2013 | $540,000 | -8.6% | 47,550 | -15.9% | 0.01% | -25.0% |
Q3 2013 | $591,000 | -11.3% | 56,550 | -2.0% | 0.01% | -20.0% |
Q2 2013 | $666,000 | – | 57,700 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TIRSCHWELL & LOEWY INC | 588,908 | $7,138,000 | 1.23% |
Granahan Investment Management | 3,693,956 | $44,771,000 | 1.21% |
NEA Management Company, LLC | 1,825,600 | $22,126,000 | 1.09% |
FIC CAPITAL INC | 150,868 | $1,829,000 | 0.75% |
Rhenman & Partners Asset Management AB | 181,797 | $2,203,000 | 0.66% |
SOPHROSYNE CAPITAL LLC | 60,200 | $728,000 | 0.64% |
HARVEY CAPITAL MANAGEMENT INC | 130,400 | $1,580,000 | 0.63% |
Artal Group S.A. | 1,300,000 | $15,756,000 | 0.57% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 564,418 | $6,840,000 | 0.47% |
OppenheimerFunds, Inc. | 24,400,000 | $295,728,000 | 0.35% |